Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1. Describe the characteristics and epidemiology of the main VBDs in the European region;
2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and
3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.

Moderator:
- Sari Westermarck, Community pharmacist, Finland

Panellists:
- Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes, Denmark

- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia, Spain

- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology, Turkey

- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union, Bulgaria

With the publication of the document FIP Vector-Borne Diseases: A Handbook for Pharmacists, produced in collaboration with the Pharmaceutical Forum of the Americas (PFA), the International Pharmaceutical Federation (FIP) offers an overview of these pathologies and notes that pharmacists are uniquely positioned to help communities and patients protect themselves from them. This webinar will describe the most prevalent vector-borne diseases in the Southeast Asian region; subsequently, the pharmaceutical interventions that this professional can carry out will be identified and finally the experiences developed by the SEAR Pham Forum regarding the pharmaceutical approach to Vector Borne diseases will be presented.

1) Recognize the main concepts related to vector-borne diseases.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region of the Southeast Asia.
3) Determine the activities that the pharmacist can develop from the pharmacy for the prevention, detection, control, and management of pharmacotherapy of vector-borne diseases.
4) Identify the experiences developed by the SEAR Pham Forum to support the actions of pharmacists in the fight against diseases transmitted by vectors

Moderator:
-T.V. Narayana, President, SEAR Pharm Forum, President Indian Pharmaceutical Association - India
Facilitator:
-Manisha Shridhar, Regional Advisor, IPR, Trade&Health, WHO-SEARO - India

Speakers:
- Manjiri Gharat, FIP Vice-President, Vice-President of Indian Pharmaceutical Association (IPA) and Chairperson of IPA Comm.Ph.Division; Executive Committee Member, SEARPharm Forum of FIP and WHO; Principal K. M. Kundnani Pharmacy - India
- Chinta Abayawardana, FIP Members Organization/ Individual Member, General Secretary Pharmaceutical Society of Sri Lanka - Sri Lanka
- David C. Yohanes, Clinical Pharmacist Clinical pharmacist in Bandung Hospital - Indonesia
- Yagya Prasad Neupane, Ex-Chairmen Nepal Pharmacy Council -Nepal

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Western Pacific region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

1) Identify the most prevalent vector-borne diseases in the Western Pacific region.

2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.

3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderator:
John Jackson, President, Western Pacific Pharmaceutical Forum

Panellists:
- Aya Yajima, NTD focal point, Malaria and Neglected Tropical Diseases Unit, WHO Regional Office for the Western Pacific
- James Kelly, Malaria Focal Point, WHO WPRO
- Renly Lim, Research Fellow, University of South Australia, FIP YPG President
- Judilynn Solidum, Professor, University of the Philippines College of Pharmacy

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Eastern Mediterranean region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1) Identify the most prevalent vector-borne diseases in the Eastern Mediterranean region.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.
3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderators:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University - United Arab Emirates (UAE)
- Wael Ali, President, President Egyptian organization of pharmacy. (EOP) - Egypt

Panellists:
- Rula Darwish, Professor, University of Jordan, Jordan
- Sherif Kamal, Director of pharmaceutical services, Children’s Cancer Hospital- Egypt
- Nidhal Marie, Prof Dr in the School of Pharmacy, Almustansirya University-Iraq - Iraq
- Yousif Adam Ahmed Sabeel, Director, Planning and Policy Department, National Medical Supplies Fund - Sudan

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the African region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.
Learning objectives:
1) Identify the most prevalent vector-borne diseases in the African region.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.
3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Moderator:
Arinola Joda, Associate Professor, Clinical Pharmacy, Faculty of Pharmacy, University of Lagos - Asst. Secretary/Editor in Chief, APF -Nigeria

Panellists:
- Lilyana Dayo, County Malaria Program Officer and Senior Advisor, Health System Strengthening, County Malaria Program, Kisumu - Kenya
- Azuka Oparah, Professor, Faculty of Pharmacy, University of Benin, Edo State -Nigeria
- James Frimpong, Deputy Programme Manager, National Malaria Control Programme (NMCP) - Ghana
- Folasade Lawal, MD/CEO Victory Drugs Limited, Festac, Lagos- Nigeria
- Gisele Etame, Pharmacist and associate professor; Faculty of medicine and pharmaceutical sciences, University of Douala - Cameroon

Los farmacéuticos tienen una posición privilegiada para ayudar a las comunidades y a los pacientes a protegerse de las enfermedades transmitidas por vectores (ETV). En este webinar se describirán las ETV con mayor prevalencia en las Américas; posteriormente se identificaran las intervenciones farmacéuticas más relevantes en este ámbito y por último se presentarán tres experiencias desarrolladas por el Foro Farmacéutico de las Américas referentes al abordaje farmacéutico de las ETV.

Objetivos de aprendizaje:
1) Reconocer los principales conceptos relacionados con las enfermedades transmisibles por vectores.
2) Describir las características y la morbi-mortalidad de las principales enfermedades transmisibles por vectores en la región de las Américas.
3) Determinar las actividades que el farmacéutico puede desarrollar desde la farmacia para la prevención, detección, control y gestión de la farmacoterapia de las enfermedades transmisibles por vectores.
4) Identificar las experiencias desarrolladas por el Foro Farmacéutico de las Américas para apoyar las acciones de los farmacéuticos en la lucha contra las enfermedades transmisibles por arbovirus.

Moderator:
Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica Farmacéutica
Federación Internacional Farmacéutica (FIP) - Portugal
Facilitator:
Yajaira Quesada Rojas, Secretaria Técnica - Foro Farmacéutico de las Américas - Costa Rica.

Ponentes:
-Cristina Fernández Barrantes, Farmacéutica, Centro de Información de Medicamentos del Servicio de Farmacia del Hospital San Juan de Dios, San José-Costa Rica
-Nuria Montero Chinchilla, Farmacéutica, Directora de Práctica Farmacéutica
Foro Farma-Costa Rica.
-Sofía Segura Cano, Farmacéutica, Programa Institucional para la Persona Adulta y Adulta Mayor de la Universitad Costa Rica